Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Boostability of Three Different Rabies Pre-exposure Prophylaxis Regimens
NCT07455318Phase 3Not yet recruiting
- Sponsor
- Institute of Tropical Medicine Antwerp
- Start
- May 2026
- Primary completion
- Jun 2027
- Modality
- Whole Inactivated Vaccines
- Countries
- 1
01
Overview
Phase 3, open-label trial of Rabies vaccine in rabies (3 arms), sponsored by Institute of Tropical Medicine Antwerp. Primary endpoint: Boostability at 13 months. Planned start May 2026; status: not yet recruiting.
02
Drugs
Rabies vaccine
03
Conditions
rabies
Beyond the preview
Go deeper on NCT07455318.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07455318.